Clicky

NEWRON PHARMACEUT. EO-20(NP5) News

NP5 price today by TradingView
Date Title
May 12 Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)
Mar 11 Newron Pharmaceuticals to Participate in a Fireside Chat at the 37th Annual ROTH Conference